Mainline Biosciences Raises RMB 100M in Series A Financing for Peptide Drugs
Mainline Biosciences, a polypeptide drug developer based in Zhongshan, has reportedly raised close to RMB...
Jiangsu Trausim Raises RMB 100M in Series A Financing for Dental Implants
China-based Jiangsu Trausim Medical Instrument Co., Ltd, a wholly-owned subsidiary of Fulong Holdings and focused...
Cyramza Prescribed in China for Advanced Gastric Cancer
Cyramza (ramucirumab) was first prescribed on November 6, 2022, at the Zhongshan Hospital in Shanghai...
Merck KGaA Collaborates with Biotheus to Accelerate Cell Line Characterization
German pharmaceutical giant Merck KGaA (ETR: MRK) has announced a collaboration with Biotheus, a China-based...
Merck’s Keytruda Receives 10th Indication Approval in China for TNBC
US-based Merck Sharp & Dohme’s (MSD, NYSE: MRK) programmed death-1 (PD-1) inhibitor Keytruda (pembrolizumab) has...
Takeda Partners with CCCMHPIE to Boost Rare Disease Drug Access in China
The 5th China International Import Expo (CIIE) saw Japan-based Takeda Pharmaceutical Co., Ltd’s China unit...
Xellsmart Raises RMB 200M in Series A1 Round for Stem-Cell Therapies
Xellsmart, a stem-cell startup based in Suzhou, has reportedly raised over RMB 200 million (USD...
Novo Nordisk Reports 16% YOY Growth in Q3, Raises Full-Year Guidance
Denmark-based biopharma Novo Nordisk A/S (NYSE: NVO) has released its Q3 2022 earnings report. The...
Novo Nordisk Partners with Shanghai Pharma for Smart Logistics at CIIE
Novo Nordisk (NYSE: NVO) has announced a strategic partnership with China’s Shanghai Pharmaceuticals (HKG: 2607,...
SIMR Biotechnology Raises RMB 150M in Series C1 Financing Round
China’s Shanghai SIMR Biotechnology Co., Ltd has reportedly raised RMB 150 million (USD 20.7 million)...
PingAn Good Doctor Partners with Roche and OrigiMed at CIIE
The 5th China International Import Expo (CIIE) saw China-based Ping An Healthcare and Technology Co.,...
Organon Partners with Alibaba Health to Enhance Chronic Disease Management
Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health that...
Qilu Pharma’s QL1706 Shows Promise in Phase II Cervical Cancer Study
China-based Qilu Pharmaceutical has published the latest results from a Phase II clinical study for...
Organon Sponsors Retail Pharmacy Health Center at CIIE
The 5th China International Import Expo (CIIE) saw Organon & Co. (NYSE: OGN), a firm...
Sanofi Partners with China Resources Sanjiu at CIIE for Consumer Healthcare
The 5th China International Import Expo (CIIE) saw Sanofi’s consumer healthcare unit announce a partnership...
Sumitomo Dainippon Partners with Profex to Promote Antipsychotics in China
Japan-based Sumitomo Dainippon Pharma Co., Ltd has announced a partnership with Profex, a trade company...
Eli Lilly Partners with AmoyDx and Burning Rock for Retevmo Companion Diagnostics
The 5th China International Import Expo (CIIE) saw US-based Eli Lilly (NYSE: LLY) announce a...
BioNTech’s Comirnaty Gets Limited Authorization in China Amid Scholz Visit
Germany-based mRNA specialist BioNTech (NASDAQ: BNTX) reportedly benefited from German Chancellor Olaf Scholz’s visit to...
Organon’s Q3 Results Show Women’s Health Segment Outperforms Amid Global Revenue Decline
US-based Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health...
Organon Signs MOU with China’s National Health Commission at CIIE
Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health that...